Medigus Ltd Wt Stock EBITDA
Medigus Ltd WT fundamentals help investors to digest information that contributes to Medigus' financial success or failures. It also enables traders to predict the movement of Medigus Stock. The fundamental analysis module provides a way to measure Medigus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigus stock.
Medigus |
Medigus Ltd WT Company EBITDA Analysis
Medigus' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Medigus EBITDA | (11.99 M) |
Most of Medigus' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigus Ltd WT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Medigus Ltd WT reported earnings before interest,tax, depreciation and amortization of (11.99 Million). This is much lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is notably higher than that of the company.
Medigus EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigus' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medigus could also be used in its relative valuation, which is a method of valuing Medigus by comparing valuation metrics of similar companies.Medigus is currently under evaluation in ebitda category among its peers.
Medigus Fundamentals
| Number Of Shares Shorted | 285 | |||
| Revenue | 91.86 M | |||
| EBITDA | (11.99 M) | |||
| Net Income | (10.1 M) | |||
| Total Debt | 10.13 M | |||
| Cash Flow From Operations | (5.66 M) | |||
| Total Asset | 97.65 M | |||
| Retained Earnings | (85.59 M) | |||
| Working Capital | 14.63 M | |||
| Z Score | -0.51 | |||
| Net Asset | 97.65 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd WT check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |